RxDoctor Payments Data

Shawn Gurtcheff

Reproductive Endocrinology · Pleasant Grove, UTNPI 1952353930

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $66,225 of the $75,430 with a category attached, or 87.8%. AbbVie accounts for 99.1% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $65,410 and has fallen 99.8% since, to $121 in 2025.

$75,430in general payments, 2019–2025

Across 143 payments — averaging $527.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$75K
  • EMD Serono, Inc.$353
  • Ferring Pharmaceuticals Inc.$223
  • Organon$63
  • Hologic Sales And Service, LLC$62
$353,840in research payments, 2019–2025

Across 21 payments — averaging $16,850 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • IBSA Institut Biochimique SA$354K

What the payments were for

  • Speaking & faculty fees$66,22588%
  • Travel & lodging$6,7829%
  • Food & beverage$2,3643%
  • Education$590%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few reproductive endocrinology providers in Utahto place this figure against a meaningful peer group, so we don't.

Other reproductive endocrinology in Pleasant Grove

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →